Regulatory Roundup: International Conference on Harmonization Hosts a Series of New Training Sessions - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: International Conference on Harmonization Hosts a Series of New Training Sessions

ePT--the Electronic Newsletter of Pharmaceutical Technology

The International Conference on Harmonization (ICH) is hosting a series of new training sessions this spring. A follow-up training program to the organizations ICH Q8, Q9, and Q10 Quality Implementation program will take place in Japan. The workshop will provide comprehensive information on the integrated quality-trio guidelines and is cosponsored by the Japan Pharmaceutical Manufacturers Association and the Pharmaceutical and Medical Device Regulatory Science Society of Japan.

In related news, the ICH Global Cooperation Group (GCG) endorsed the SADC training for regulators on the ICH Q7 guideline (GMP for APIs). The training is scheduled for this summer in Tanzania. GCC also endorsed ASEAN's request for training regulators and industry on the ICH Q5C guideline (quality of biotechnological products) and that training will take place this spring Kuala Lumpur. Finally, GCC endorsed a request for training on the ICH Q5 series of guidelines (Q5A - Q5E) on quality of biotechnological products, which will take place in spring 2011. Visit the ICH website for further details on these programs.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here